Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease.
D000224:Addison Disease / Q000150:complications / Q000276:immunology; D000328:Adult; D000752:Anemia, Pernicious / Q000150:complications / Q000276:immunology; D001323:Autoantibodies / Q000302:isolation & purification*; D001327:Autoimmune Diseases; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000302:isolation & purification; D007136:Immunoglobulins / Q000302:isolation & purification; D007328:Insulin / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000276:immunology*; D008297:Male; D008599:Menstruation Disturbances / Q000150:complications / Q000276:immunology; D008875:Middle Aged; D009928:Organ Specificity; D012737:Sex Factors; D013959:Thyroid Diseases / Q000150:complications / Q000276:immunology
D001323:Autoantibodies; D007074:Immunoglobulin G; D007136:Immunoglobulins; D007328:Insulin